BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9742033)

  • 1. Role of fecal occult-blood testing.
    Bond JH; Mandel JS; Church TR
    N Engl J Med; 1998 Sep; 339(11):774-5. PubMed ID: 9742033
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should all people over the age of 50 have regular fecal occult-blood tests? Postpone population screening until problems are solved.
    Simon JB
    N Engl J Med; 1998 Apr; 338(16):1151-2; discussion 1154-5. PubMed ID: 9545367
    [No Abstract]   [Full Text] [Related]  

  • 4. Colorectal cancer screening.
    Cher DJ
    J Public Health Med; 1993 Jun; 15(2):211-2. PubMed ID: 8353013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
    Edwards JB
    Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Ransohoff DF; Pignone M
    N Engl J Med; 2001 Mar; 344(13):1022-3. PubMed ID: 11280325
    [No Abstract]   [Full Text] [Related]  

  • 8. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should all people over the age of 50 have regular fecal occult-blood tests? If it works, why not do it?
    Fletcher RH
    N Engl J Med; 1998 Apr; 338(16):1153-4; discussion 1154-5. PubMed ID: 9547141
    [No Abstract]   [Full Text] [Related]  

  • 10. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
    Yamamoto M; Nakama H
    Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of three stool tests for colorectal cancer screening.
    Greenwald B
    Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it time to recommend screening for colorectal cancer?
    Lieberman D; Sleisenger MH
    Lancet; 1996 Nov; 348(9040):1463-4. PubMed ID: 8942770
    [No Abstract]   [Full Text] [Related]  

  • 14. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for population-based screening for colorectal cancer.
    Schoen RE
    Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal occult blood screening for colorectal cancer.
    Van Dam J; Bond JH; Sivak MV
    Arch Intern Med; 1995 Dec 11-25; 155(22):2389-402. PubMed ID: 7503597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the most cost-effective screening regimen for colon cancer?
    Griffith S; Kane KY
    J Fam Pract; 2001 Jan; 50(1):13. PubMed ID: 11195472
    [No Abstract]   [Full Text] [Related]  

  • 19. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and surveillance for colorectal cancer.
    Schnoll-Sussman F; Markowitz AJ; Winawer SJ
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):10-21. PubMed ID: 11049028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.